Polyenylphosphatidylcholine decreases alcoholic hyperlipemia without affecting the alcohol-induced rise of HDL-cholesterol

Life Sciences

Volumn 61, Issue 19, 1997, Pages 1907-1914

  Navder, Khursheed P ^a,b   Baraona, Enrique ^d   Lieber, Charles S ^a,c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NONE

Author keywords

Alcohol; Polyenylphosphatidylcholine; Rats; Serum lipoproteins

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE;

ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FAT INTAKE; FATTY LIVER; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPID ABSORPTION; LIPOPROTEIN BLOOD LEVEL; LIVER MEMBRANE; NONHUMAN; RAT;

ANIMALS; ANTILIPEMIC AGENTS; CHOLESTEROL, HDL; DISEASE MODELS, ANIMAL; ETHANOL; HYPERLIPIDEMIAS; LIPOPROTEINS; PHOSPHATIDYLCHOLINES; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES;

ANIMALIA; GLYCINE MAX;

EID: 0030729798     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00830-8     Document Type: Article

References (41)

1. O. ZIERENBERG and S.M. GRUNDY, J. Lipid Res. 23 1136-1142 (1982).
2. D. LEKIM and H. BETZING, Arzneim. Forsch (Drug Research) 24 1217-1221 (1974).
3. C.S. LIEBER, L.M. DECARLI, K.M. MAK, C-I. KIM, and M.A.LEO, Hepatology 12 1390-1398 (1990).
4. C.S. LIEBER, S.J. ROBINS, J. LI, L.M. DECARLI, K.M. MAK, J.M. FASULO, and M.A. LEO, Gastroenterology 106 152-159 (1994).
5. K.P. NAVDER, E. BARAONA and C.S. LIEBER, Gastroenterology 110 1275 (1996).
6. C.H. HENNEKENS, Alcohol and the Cardiovascular System,S. Zakhari and M. Wassef (Eds.), 15-24, NIH Research Monograph No.31, Bethesda, MD (1996)
7. L.L. RUDEL, C.W. LEATHERS, M.G. BOND and B.C. BULLOCK, Atherosclerosis 1 144-155 (1981)
8. W.P. CASTELLI, J.T. DOYLE, T. GORDON, C.O. HAMES, M.C. HORTLAND, S.B. HULLEY, A. KAGAN, and W.J. ZUKEL, Lancet 2 153-155 (1977) .
9. M.A. JIMENEZ, M.L. SCARINO, F. VIGNOLINI and E. MENGHERI, J. Nutr. 120 659-667 (1990).
10. J.T. KNUIMAN, A.C. BEYNEN and M.B. KATAN, Am. J. Nutr. 49 266-268 (1989)
11. C.S. LIEBER and L.M. DECARLI, Methods in Enzymology 233 585-594 (1994).
12. E. BARAONA and C.S. LIEBER, J. Clin. Invest. 49 769-778 (1970).
13. R.J. HAVEL, H.A. EDER and J.H. BRAGDON, J. Clin. Invest. 34 1345-1353 (1955).
14. N.L. LASSER, P.S. ROHEIM, D. EDELSTEIN, and H.A. EDER, J. Lipid Res. 14 1-8 (1973).
15. R.P. NOBLE, J. Lipid Res. 9 693-700 (1968).
16. A. W. WAHLEFELD, Methods of Enzymatic Analysis, vol. 4 , H.U. Bergmeyer (Ed.), 1881-1885, Academic Press, New York (1974).
17. C.C. ALLAIN, L.S. POON, C.S.G. CHAN, W. RICHMOND, and P.C. FU, Clin. Chem. 20 470-475 (1974).
18. M. NOVÁK, J. Lipid Res. 6 431-433 (1965).
19. F. SNYDER and N.A. STEPHENS, Biochim. Biophys. Acta 34 244-245 (1959).
20. J.D. AMENTA, J. Lipid Res. 5 270-272 (1964).
21. J. FOLCH, M. LEES & G.H. SLOAN-STANLEY, J. Biol. Chem. 226 497-509 (1957).
22. R.L. SEARCY and L.M. BERQUIST, Clin. Chim. Acta 5 192-199 (1960).
23. O.H. LOWRY, N.J. ROSEBROUGH, A.L. FARR, and R.J. RANDALL, J. Biol. Chem. 193 265-275 (1951).
24. J.H. VAN DE KAMER, B. HUININK, and H.A. WEYERS, J. Biol. Chem. 177 347-355 (1949).
25. E. BARAONA, R. PIROLA and C.S. LIEBER, J. Clin. Invest. 52 296-303 (1973).
26. M. ROSSENEU, B. DECLERCQ, D. VANDAMME, R. VERCAEMST, F. SOETEWEY, H. PEETERS and V. BLATON, Atherosclerosis 32 141-153 (1979).
27. S. BENNETT CLARK, V.E. CLARK and D.M. SMALL, Am. J. Physiol. 241 G422-G430 (1981).
28. E. MENGHERI, M. L. SCARINO, F. VIGNOLINI and M.A. SPADONI, Br. J. Nutr. 53 223-232 (1985).
29. T. IWATA, S. HOSHI, F. TAKEHISA, K. TSUTSUMI, Y. FURUKAWA and S. KIMURA, J. Nutr. Sci. Vitaminol. 38 471-479 (1992).
30. F. RIOUX, A. PEREA, I.M. YOUSEF, E. LEVY, L. MALLI, M.C. CARRILLO, and B. TUCHWEBER, Biochim. Biophys. Acta 1214 193-202 (1994).
31. E. POLICHETTI, N. DIACONESCU, P. LECHENE DE LA PORTE, L. MALLI, H. PORTUGAL, A-M. PAULI, H. LAFONT, B. TUCHWEBER, I. YOUSEF and F. CHANUSSOT, Br. J. Nutr.75 471-481 (1996).
32. M.T. CHILDS, J.A. BOWLIN, J.T. OGILVIE, W.R. HAZZARD, and J.J. ALBERS, Atherosclerosis 38 217-228 (1981).
33. G. NOSEDA and C. Fragiacomo, 50th Anniversary of Phospholipid Research (EPL), K-J. Gundermann and R. Schumacher (Eds.), 177-184, wbn-Verlag, Bingen/Rhein (1990).
34. R. KIRSTEN, B. HEINTZ, K. NELSON, E. SCHNEIDER, G. OREMEK, and N. NEMETH, Int. J. Clin. Pharmacol. Ther. Toxicol. 32 533-56 (1994).
35. Y.A. KESANIEMI and S.M. GRUNDY, Amer. J. Clin. Nutr. 43 98-107 (1986).
36. M.J. SAVOLAINEN, E. BARAONA, M.A. LEO, and C.S. LIEBER, J. Lipid Res. 27 1073-1083 (1986).
37. F.U. BEIL and S.M. GRUNDY, J. Lipid Res. 21 525-536 (1980).
38. D. HOLLANDER and D. MORGAN, Lipids 15 395-400 (1980).
39. J.E. O'MULLANE and J.N. HAWTHORNE, Atherosclerosis 45 81-90 (1982).
40. J.P. MALASPINA, H. BUSSIERE and G. LE CALVE, Atherosclerosis 40 373-375 (1981).
41. B. KINOSIAN, H. GLICK, L. PREISS and K.L. PUDER: J. Investig. Med. 43 443-450 (1995)